| Name | Title | Contact Details |
|---|
Southern Scripts provides innovative and transformative pharmacy benefit management (PBM) solutions that guarantee employers complete flexibility and control over their benefit plan.
Caregiver, Inc. is one of the largest providers of support services to people with intellectual and developmental disabilities and traumatic brain injury in the United States. We currently operate in Texas and Tennessee under multiple local brands, including: Daybreak Community Services Unified Care Group Southern Concepts River Gardens St. Giles Omni Support Services/Caregiver of Tennessee Our Mission is "Enabling people with intellectual and developmental disabilities to lead their unique lives with dignity, independence and inclusion." We believe in recruiting, training and developing the best people to support the individuals we serve; enabling them with tools and technology to provide individualized supports. We care deeply about the people we serve and strive to serve their unique goals and dreams. We work with integrity, accountability, transparency, and compassion in everything we do, because we understand those we serve have a choice in providers. We offer residential, intermediate care facility, supported living/foster care, day support, community integration and employment support services in both Texas and Tennessee. In addition, Caregiver has a newly developed Behavioral Support Services team supporting those we serve in Texas.
Universal Rhblttion Ftnes Inst is a Livingston, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Freeport Health Network/Freeport Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Freeport, IL. To find more information about Freeport Health Network/Freeport Memorial Hospital, please visit www.fhn.org
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.